Humana Inc. $HUM Shares Sold by Intech Investment Management LLC

Intech Investment Management LLC reduced its position in Humana Inc. (NYSE:HUM) by 44.1% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 8,533 shares of the insurance provider’s stock after selling 6,735 shares during the quarter. Intech Investment Management LLC’s holdings in Humana were worth $2,186,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of HUM. Capital International Investors acquired a new position in Humana in the 3rd quarter valued at $707,670,000. Massachusetts Financial Services Co. MA increased its stake in Humana by 28.9% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after buying an additional 1,008,514 shares during the period. Neuberger Berman Group LLC increased its stake in Humana by 2,855.5% in the 3rd quarter. Neuberger Berman Group LLC now owns 530,775 shares of the insurance provider’s stock valued at $138,092,000 after buying an additional 512,816 shares during the period. 8 Knots Management LLC increased its stake in Humana by 671.0% in the 2nd quarter. 8 Knots Management LLC now owns 441,623 shares of the insurance provider’s stock valued at $107,968,000 after buying an additional 384,345 shares during the period. Finally, Man Group plc increased its stake in Humana by 179.5% in the 2nd quarter. Man Group plc now owns 580,943 shares of the insurance provider’s stock valued at $142,029,000 after buying an additional 373,071 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Price Performance

Shares of NYSE HUM opened at $328.09 on Thursday. The firm has a market capitalization of $39.39 billion, a P/E ratio of 35.09, a PEG ratio of 2.33 and a beta of 0.76. Humana Inc. has a one year low of $163.11 and a one year high of $333.31. The company’s fifty day moving average is $241.36 and its two-hundred day moving average is $230.78. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. During the same period in the previous year, the firm earned $11.58 EPS. The business’s revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. Analysts forecast that Humana Inc. will post 9 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.1%. Humana’s payout ratio is currently 37.86%.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on HUM shares. William Blair began coverage on shares of Humana in a research note on Wednesday, May 20th. They issued an “outperform” rating on the stock. Needham & Company LLC began coverage on shares of Humana in a research report on Wednesday, May 20th. They set a “buy” rating on the stock. Zacks Research upgraded shares of Humana from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 13th. TD Cowen boosted their target price on shares of Humana from $173.00 to $211.00 and gave the stock a “hold” rating in a research report on Friday, May 1st. Finally, Piper Sandler restated a “neutral” rating and set a $254.00 target price (up from $182.00) on shares of Humana in a research report on Wednesday, May 13th. Nine investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $276.17.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.